APOGEPHA International
For over 25 years, we have been continuously and successfully expanding our international network for the marketing and distribution of our proprietary drug development containing the active ingredient propiverine for the treatment of bladder weakness (overactive bladder and neurogenic detrusor hyperactivity) in adults and children under the brands Mictonorm®, Detrunorm®, Mictoryl® and Propinorm®.
We are very proud that many renowned companies in more than 20 countries in Europe, Asia, Africa, North America, Latin America and South America are among our cooperation partners.
Our product is manufactured exclusively in Germany. We are committed to supporting ‘Made in Germany’ and thus guarantee excellent quality.
![[Translate to English:] Zwei Mitarbeiter von APOGEPHA lächeln freundlich.](/fileadmin/_processed_/e/a/csm_csm_mandel-beier-web_6af29e6df9_e53b17fe6d.png)
Log-in for sales partners
We have compiled an extensive collection of publications, materials and information for our international partners in the partner portal.
New Countries and Products
Our country map shows you which countries APOGEPHA already has distribution partners in.
APOGEPHA is constantly expanding its portfolio and welcomes new cooperation partners with a focus on urology/gynaecology in countries where it is not yet represented.
We are also seeking new products that align perfectly with our core competencies.
Please contact us if you are interested or have any questions about new countries or new products!